[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587742":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":33,"centralContacts":37,"locations":42,"responsibleParty":82,"collaborators":12,"id":84,"slug":85,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":12,"eligibilityCriteria":90,"healthyVolunteers":86,"sex":91,"minAge":12,"maxAge":92,"enrollmentInfo":93,"targetDuration":12,"studyType":96,"phases":97,"briefSummary":99,"conditions":100,"keywords":102,"overallStatus":45,"whyStopped":12,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Johns Hopkins University","OTHER",[8,13,19],{"label":9,"type":10,"description":11,"interventionNames":12},"No EHR-Alert","NO_INTERVENTION","Clinicians will not be exposed to a any EHR-alert about the care of bronchiolitis. The participants will still have access to the EHR-embedded, evidence-based clinical guideline.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Interruptive EHR-Alert","EXPERIMENTAL","Clinicians will be exposed to an interruptive EHR-alert directing the clinician to reference the EHR-embedded, evidence-based clinical guideline for the care of bronchiolitis.",[18],"Other: Interruptive",{"label":20,"type":15,"description":21,"interventionNames":22},"Non-interruptive EHR-Alert","Clinicians will be exposed to an non-interruptive EHR-Alert directing the clinician to reference the EHR-embedded, evidence-based clinical guideline for the care of bronchiolitis.",[23],"Other: Non-interruptive",[25,29],{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":12},"Non-interruptive","The non-interruptive EHR alert appears as a visual cue but does not require clinicians to alter workflows. The alert directs clinicians to reference the EHR-embedded, evidence-based clinical guideline for the care of bronchiolitis.",[20],{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":12},"Interruptive","The interruptive EHR alert requires clinicians to interact with the alert to continue the workflow. The alert directs clinicians to reference the EHR-embedded, evidence-based clinical guideline for the care of bronchiolitis.",[14],[34],{"name":35,"affiliation":5,"role":36},"Benjamin E Bodnar, MD","PRINCIPAL_INVESTIGATOR",[38],{"name":35,"role":39,"phone":40,"phoneExt":12,"email":41},"CONTACT","410-614-4474","bbodnar2@jh.edu",[43,62,74],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Johns Hopkins All Children's Hospital","RECRUITING","St. Petersburg","Florida","33701","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-82.67927,27.77086,{"lat":55,"lon":54},[58],{"name":59,"role":39,"phone":60,"phoneExt":12,"email":61},"Johns Hopkins IRB Office","410-502-2092","jhmeirb@jhmi.edu",{"facility":63,"status":45,"city":64,"state":65,"zip":66,"country":49,"countryCode":50,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"Johns Hopkins Bayview Medical Center","Baltimore","Maryland","21224",{"type":52,"coordinates":68},[69,70],-76.61219,39.29038,{"lat":70,"lon":69},[73],{"name":59,"role":39,"phone":60,"phoneExt":12,"email":61},{"facility":75,"status":45,"city":64,"state":65,"zip":76,"country":49,"countryCode":50,"cosmosGeoPoint":77,"geoPoint":79,"contacts":80},"Johns Hopkins Children's Center","21287",{"type":52,"coordinates":78},[69,70],{"lat":70,"lon":69},[81],{"name":59,"role":39,"phone":60,"phoneExt":12,"email":61},{"type":83,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100587742","evaluation-of-the-impact-of-ehr-alerts-on-clinical-decision-support-pathway-use-in-bronchiolitis-and-the-impact-of-pathway-use-on-the-prescription-of-high-flow-nasal-cannula-and-other-elements-of-high-value-care-100587742",false,"NCT06932341","Evaluation of the Impact of EHR-Alerts on Clinical Decision Support Pathway Use in Bronchiolitis, and the Impact of Pathway Use on the Prescription of High Flow Nasal Cannula and Other Elements of High Value Care.","The Impact of EHR-Alerts on the Use of an EHR-Integrated Clinical Decision Support Pathway and the Use of High Flow Nasal Cannula in Bronchiolitis","Patient Inclusion Criteria:\n\n* Children \\\u003C=24 months of age presenting to the emergency room and\u002For hospitalized (under observation or inpatient status) with EHR-indicators of bronchiolitis at one of three study sites. EHR-indicators of bronchiolitis include the use of bronchiolitis-specific order sets, or specific combinations of ED chief complaint, infection or isolation status, and the receipt of disease-relevant therapies (such as oxygen supplementation)\n\nPatient Exclusion Criteria:\n\n* Current encounter is birth-encounter\n* Currently hospitalized in an ICU\n* Hospitalized with length of stay \\>14 days","ALL","24 Months",{"count":94,"type":95},8000,"ESTIMATED","INTERVENTIONAL",[98],"NA","The goal of this experimental study is to learn whether different types of Electronic Health Record (EHR) alerts that direct clinicians to reference clinical guidelines embedded in the increase the use of these guidelines and the delivery of evidence-based care in children presenting to the hospital with bronchiolitis. The main questions it aims to answer are:\n\n* Do EHR-alerts increase clinicians' us of evidence-based EHR-integrated Clinical Decision Support (CDS) guidelines for the care of bronchiolitis and\n* Is the use of EHR-integrated CDS-guidelines for the care of bronchiolitis associated with deceases in low-value use of High Flow Nasal Cannula (HFNC) and improvement in other aspects of high-value care for this disease\n\nPatients will be randomized on the encounter-level to have the patient's treating providers receive no EHR-alert or one of two types of EHR-alert (non-interruptive or interruptive) reminding the provider that the EHR-integrated CDS guideline is available for the care or bronchiolitis. Researchers will compare the rate of use of EHR-integrated CDS guidelines in patients whose clinicians did not receive any EHR-alerts, to those whose clinicians received a non-interruptive alert and to those whose clinicians received an interruptive Best Practice Advisory (BPA). In addition, the study will evaluate whether the utilization of the EHR-integrated CDS guideline in a given encounter was associated with less low-value HFNC use, and differences in other elements of low-value care for bronchiolitis.\n\nPatients in all groups will continue to receive standard hospital care for bronchiolitis as determined by the patient's treating clinicians.",[101],"Bronchiolitis",[103,104,105,106,107,108],"best practice advisory","clinical decision support","clinical guideline","clinical pathway","practice advisory","EHR alert","2026-05-26",{"date":111,"type":112},"2026-05-29","ACTUAL",{"date":114,"type":112},"2025-05-05",{"date":116,"type":95},"2026-07-14",{"name":5,"class":6},3]